PDL Biopharma
PDLI
#8394
Rank
ยฃ0.21 B
Marketcap
ยฃ1.89
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -ยฃ0.11 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are ยฃ80.61 Million. In 2019 the company made an earning of -ยฃ47.66 Million a decrease over its 2018 earnings that were of -ยฃ33.46 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-ยฃ0.11 Billion117.81%
2019-ยฃ47.66 Million42.43%
2018-ยฃ33.46 Million-121.38%
2017ยฃ0.15 B60.41%
2016ยฃ97.56 M-77.09%
2015ยฃ0.42 B3.09%
2014ยฃ0.41 B26.65%
2013ยฃ0.32 B19.82%
2012ยฃ0.27 B3.68%
2011ยฃ0.26 B77.17%
2010ยฃ0.14 B-35.29%
2009ยฃ0.22 B23.45%
2008ยฃ0.18 B-1751.42%
2007-ยฃ11.24 Million-88.56%
2006-ยฃ98.19 Million93.73%
2005-ยฃ50.68 Million13.63%
2004-ยฃ44.61 Million32.12%
2003-ยฃ33.76 Million87.44%
2002-ยฃ18.01 Million-302.45%
2001ยฃ8.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
ยฃ26.57 B-26,529.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.44 B-8,501.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ84.34 Million-16.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ26.66 M-126.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-ยฃ0.12 Billion 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA